International Biotechnology Trust’s Rocket Pharmaceuticals RCKT Stock Holding History

International Biotechnology Trust’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.19M	Hold	156,000	–	–	1.08%	28
2023 Q2	$3.09M	Buy	156,000 +93,000	+148%	+$1.88M	0.94%	33
2023 Q1	$1.08M	Hold	63,000	–	–	0.3%	48
2022 Q4	$1.23M	Hold	63,000	–	–	0.38%	47
2022 Q3	$1M	Buy	63,000 +62,132	+7,158%	+$970K	0.32%	52
2022 Q2	$63K	Sell	868 -62,132	-99%	-$741K	0.66%	35
2022 Q1	$17.9M	Hold	63,000	–	–	4.03%	8
2021 Q4	$1.38M	Hold	63,000	–	–	0.31%	51
2021 Q3	$1.88M	Buy	+63,000	New	+$2.29M	0.45%	41

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

International Biotechnology Trust's RCKT Position: Q3 2023 in Review

International Biotechnology Trust held its Rocket Pharmaceuticals (RCKT) position steady in Q3 2023 at 156,000 shares worth $3.19M. The position accounts for 1.08% of the portfolio, ranked #28.

International Biotechnology Trust first reported a position in RCKT in Q3 2021 and has held it in 9 quarters since. The position peaked at $17.9M in Q1 2022. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2023.

International Biotechnology Trust held 156,000 shares of Rocket Pharmaceuticals worth $3.19M as of Q3 2023.
International Biotechnology Trust left its Rocket Pharmaceuticals share count unchanged in Q3 2023.
Rocket Pharmaceuticals made up 1.08% of International Biotechnology Trust's portfolio in Q3 2023, its #28 holding.
International Biotechnology Trust first reported a position in Rocket Pharmaceuticals in Q3 2021 and has held it in 9 quarters since.
International Biotechnology Trust's Rocket Pharmaceuticals position peaked at $17.9M in Q1 2022.
175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.